BioMarin Pharmaceutical Inc (BMRN :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
BMRN FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
-
BioMarin's cancer drug success prompts launch of pivotal trial 03 Jun 2013 - Reuters
-
Stocks to Watch at This Year's Biotech Super Bowl 31 May 2013 - CNBC.com
-
Cramer's Watch List Ahead of Big Cancer Conference 20 May 2013 - CNBC.com
-
MORE FROM CNBC
-
-
Stocks to Watch at This Year's Biotech Super Bowl 31 May 2013 - CNBC.com
-
Cramer's Watch List Ahead of Big Cancer Conference 20 May 2013 - CNBC.com
-
LATEST TRANSCRIPTS
-
BioMarin Pharmaceutical Inc. Presents at Goldman Sachs 34th Annual Glo... 13 Jun 2013 - Seeking Alpha
-
BioMarin Pharmaceutical Inc. Presents at UBS Global Healthcare Confere... 21 May 2013 - Seeking Alpha
PRESS RELEASES
-
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Repor... 14 Jun 2013 - PR Newswire
-
UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Gold... 06 Jun 2013 - Globe Newswire
-
BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU 05 Jun 2013 - Globe Newswire
-
The Zacks Analyst Blog Highlights: Nasdaq OMX Group, Netflix, DTS, AVG... 03 Jun 2013 - PR Newswire
-
BioMarin Provides Preliminary Data on Ongoing Phase 1/2 Trial for BMN ... 03 Jun 2013 - Globe Newswire
-
BioMarin to Present at the Jefferies Global Healthcare Conference 30 May 2013 - Globe Newswire
-
FDA Accepts Vimizim BLA and Grants Priority Review Designation 30 May 2013 - Globe Newswire
-
Vimizim MAA Validated by the EMA 30 May 2013 - Globe Newswire
-
BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Li... 20 May 2013 - Globe Newswire
